Summary
p16INK4A (p16) tumour suppressor induces growth arrest by inhibiting function of cyclin-dependent kinase (CDK)4 and CDK6. Homozygous p16 gene deletion is frequent in primary rhabdomyosarcoma (RMS) cells as well as derived cell lines. To confirm the significance of p16 gene deletion in tumour biology of RMS, a temperature-sensitive p16 mutant (E119G) gene was retrovirally transfected into the human RMS cell line RD, which has homozygous gene deletion of p16 gene. Decrease from 40°C (restrictive) to 34°C (permissive) culture temperature reduced CDK6-associated kinase activity and induced G1 growth arrest. Moreover, RD-p16 cells cultured under permissive condition demonstrated differentiated morphology coupled with expressions of myogenin and myosin light chain. These suggest that deletion of p16 gene may not only facilitate growth but also inhibit the myogenic differentiation of RD RMS cells.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Andres, V. & Walsh, K. (1996). Myogen expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657–666.
Carli, M., Guglielmi, M., Sotti, G., Cecchetto, G. & Ninfo, V. (1992). Rhabdomyosarcoma. In Paediatric Oncology, Plowman PN and Pinkerton CR (eds). Chapman & Hall Medical: New York, USA 291–324.
DeGiovanni, C., Nanni, P., Nicoletti, G., Ceccarelli, C., Scotland, K., Landuzzi, L. & Lollini, P. L. (1989). Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA). Anticancer Res 9: 1943–1950.
El-Badry, O. M., Minniti, C., Kohn, E. C., Houghton, P. J., Daughaday, W. H. & Helman, L. J. (1990). Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1: 325–331.
Gu, W. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309–324.
Hatta, Y., Hirama, T., Miller, C. W., Yamada, Y., Tomonaga, M. & Loeffler, H. P. (1995). Homozygous deletion of the p15(MTS2) and p16(CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85: 2699–2740.
Havery, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D. & Lassar, A. B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by Myo D. Science 267: 1018–1021.
Hirama, T. & Koeffler, H. P. (1995). Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841–854.
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheathan, M. D., Clark, W. H. Jr, Tucker, M. A. & Dracopoli, N. C. (1994). Germline p16 mutations in familial melanoma. Nature Genet 8: 15–21.
Iolascon, A., Faienza, M. F., Coppola, B., Rosolen, A., Basso, G., Della Ragione, F. & Schettini, F. (1996). Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chrom Cancer 15: 217–222.
Mao, L., Merlo, A., Bedi, G., Shapiro, G. I., Edwards, C. D., Rollins, B. J. & Sidransky, D. (1995). A novel p16INK4A transcript. Cancer Res 55: 2995–2997.
Morgenstern, J. P. & Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587–3596.
Novitch, B. G., Mulligan, G. J., Jacks, T. & Lassar, A. B. (1996). Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulation in S and G2 phase of the cell cycle. J Cell Biol 135: 491–456.
Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y. & Hirai, H. (1994). Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 84: 2431–2435.
Parker, S. B., Eichele, G., Zhang, P., Rawls, S., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W. & Elledge, S. J. (1995). p53-independent expression of p21CIO1 in muscle and other terminally differentiating cells. Science 267: 1024–1027.
Ranade, K., Hussussian, C. J., Sikorski, R. S., Varmus, H. E., Goldstein, A. M., Tucker, M. A., Serrano, M., Hannon, G. J., Beach, D. & Dracopoli, N. C. (1995). Mutation associated with familial melanoma impairs p16INK4 function. Nature Genet 10: 114–116.
Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V. & Nadal-Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb –/– muscle cells. Science 264: 1467–1471.
Scrable, H. J., Witte, D. P., Lampkin, B. C. & Cavenee, W. K. (1987). Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329: 645–647.
Serrano, M., Hannon, G. J. & Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704–707.
Serrano, M., Lee, H-W, Chin, L., Cordon-Cardo, C., Beach, D. & DePinho, R. A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27–37.
Serrano, M., Liu, A. M., McCurrach, M. E., Beach, D. & Lowe, S. W. (1997). Oncopenic ras provokes premature all senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593–602.
Skapek, S. X., Rhee, J., Spicer, D. B. & Lassar, A. B. (1995). Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022–1024.
Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R. & Naeve, C. W. (1993). Fusion of Pax3 to a member of the fork-head family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53: 5108–5112.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G. & Kamb, A. (1995). Complex structure and regulation of the p16 (MTSl) locus. Cancer Res 55: 2988–2994.
Turc-Carel, C., Lizard-Nacol, S. & Justrabo, E. (1986). Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19: 361–362.
Urashima, M., Hoshi, Y., Sugimoto, Y., Kaihara, C., Matsuzaki, M., Chauhan, D., Ogata, A., Teoh, G., DeCaprio, J. A. & Anderson, K. C. (1996a). A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16INK4A/p15INK4B tumor suppressor and immunoglobulin heavy chain genes. Leukemia 10: 1576–1583.
Urashima, M., Ogata, A., Chauhan, D., Vidriales, M. B., Teoh, G., Hoshi, Y., Schlossman, R. L., DeCaprio, J. A. & Anderson, K. C. (1996b). Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 88: 2219–2227.
Urashima, M., Teoh, G., Ogata, A., Chauhan, D., Treon, S. P., Sugimoto, Y., Kaihara, C., Matsuzaki, M., Hoshi, Y., DeCaprio, J. A. & Anderson, K. C. (1997a). Characterization of p16INK4A expression in multiple myeloma and plasma cell leukemia. Clin Cancer Res 3: 2173–2179.
Urashima, M., Teoh, G., Chauhan, D., Hoshi, Y., Ogata, A., Treon, S. P., Schlossman, R. L. & Anderson, K. C. (1997b). Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon γ in multiple myeloma cells. Blood 90: 279–289.
Urashima, M., DeCaprio, J. A., Teoh, G., Ogata, A., Chauhan, D., Treon, S. P., Hoshi, Y. & Anderson, K. C. (1997c). p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. Blood 90: 4106–4115.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Urashima, M., Teoh, G., Akiyama, M. et al. Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells. Br J Cancer 79, 1032–1036 (1999). https://doi.org/10.1038/sj.bjc.6690165
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690165
